Bariatric Surgery: Clinical Trials

10 trials for Bariatric Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 recruiting, 2 unknown. 10 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 4, Recruiting 4, Unknown 2
Phase 21Unknown 1

Follow Bariatric Surgery: new trials by email Literature Review of Bariatric Surgery trials Research Report on Bariatric Surgery

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery
Suzetrigine, Placebo - Bariatric Surgery, Cardiac Surgery With Sternotomy
Phase 3RecruitingIcahn School of Medicine at Mount Sinai2352026-05-012026-05-14
The Incidence of Post-Operative Lung Atelectasis With Erector Spinae Plane Block in Bariatric Surgery:
ESPB - Pulmonary Atelectasis, Bariatric Surgery
Phase 3CompletedKasr El Aini Hospital1382024-11-152025-11-18
Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery
Capsulized fecal microbiota transfer containing the healthy feces + stool dilution solution, Capsulized placebo transfer containing dilution solution - Bariatric Surgery, Type 2 Diabetes
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris542024-01-212025-02-17
Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial
Duodenojejunal bypass, Sleeve gastrectomy - Diabetes Mellitus, Type 2, Bariatric Surgery
Phase 3RecruitingSeoul National University Bundang Hospital1302022-01-032022-01-27
Naldebain for Pain Control After Bariatric Surgery
Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic
Phase 2 / Phase 3UnknownE-DA Hospital602021-06-242021-12-28
Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care
Metformin, Standard Care, Standardized meal - Diabetes, Bariatric Surgery
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris1262021-01-072023-06-08
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
Blood sampling, Lidocaine - Obesity, Bariatric Surgery
Phase 3CompletedHospices Civils de Lyon502015-09-012025-12-19
Do Text Message Reminders Increase Preoperative Exercise in Obesity Surgery Candidates?
Daily text message reminders - Perioperative Care, Bariatric Surgery
Phase 3CompletedUniversity of Auckland, New Zealand1022012-08-012013-11-14
Effects of Gastric Bypass on Blood Levels of Duloxetine
Duloxetine - Bariatric Surgery
Phase 3CompletedNeuropsychiatric Research Institute, Fargo, North Dakota202009-09-012014-08-11
Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
biliopancreatic diversion, antidiabetics - Type 2 Diabetes Mellitus, Bariatric Surgery
Phase 3UnknownIRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy402009-07-012010-01-12

Narrower conditions

Diabetes Mellitus, Type 2 (3)  ·  Obesity (3)  ·  Pain, Postoperative (2)  ·  Chronic Pain (1)  ·  Diabetes Mellitus (1)  ·  Pulmonary Atelectasis (1)

Broader conditions

Nutritional and Metabolic Diseases (7)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Body Weight (3)  ·  Diabetes Mellitus (3)  ·  Nutrition Disorders (3)  ·  Overnutrition (3)  ·  Overweight (3)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathologic Processes (2)  ·  Postoperative Complications (2)

Interventions

Biliopancreatic Diversion (1)  ·  Blood Specimen Collection (1)  ·  Duloxetine Hydrochloride (1)  ·  Hypoglycemic Agents (1)  ·  Lidocaine (1)  ·  Metformin (1)  ·  Standard of Care (1)  ·  sebacoyl dinalbuphine ester (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  E-DA Hospital (1)  ·  Hospices Civils de Lyon (1)  ·  IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kasr El Aini Hospital (1)  ·  Neuropsychiatric Research Institute, Fargo, North Dakota (1)  ·  Seoul National University Bundang Hospital (1)  ·  University of Auckland, New Zealand (1)

Countries

France (3)  ·  United States (2)  ·  Egypt (1)  ·  Italy (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Andrew G Hill, MBChB, MD, EdD, FRACS, FACS (1)  ·  Chen-Fuh Lam, MD, PhD (1)  ·  Himani Bhatt, DO (1)  ·  James L Roerig, PharmD, BCPP (1)  ·  Young Suk Park (1)

Results publications

PMID 30399021

NIH funding

2019 (2)